Alnylam Pharmaceuticals(ALNY) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Citigroup Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $351
Benzinga14:41 ET
Update: Alnylam Pharmaceuticals Shares Rise After Receipt of US FDA Approval for ATTR-CM Drug
MT NewswiresMar 21 10:10 ET
Alnylam's Amvuttra Secures FDA Approval For Expanded Use For Rare Heart Disease, Stock Jumps
BenzingaMar 21 10:00 ET
Express News | Wells Fargo Maintains Equal-Weight on Alnylam Pharmaceuticals, Raises Price Target to $287
BenzingaMar 21 09:15 ET
Sector Update: Health Care Stocks Steady Premarket Friday
MT NewswiresMar 21 09:11 ET
Sector Update: Health Care
MT NewswiresMar 21 08:51 ET

Comments

Jerry Kronenberg

23 minutes ago

Columns Wall Street Today: Nasdaq Composite, S&P 500 and DJIA All Eke Out Gains

The Nasdaq Composite Index, S&P 500 and Dow Jones Industrial Average all rose slightly Friday during a session that failed to produce much volatility despite being 2025's first "triple-witching day."
After trading lower for much of the session, the $Nasdaq Composite Index (.IXIC.US)$ rebounded in Friday's final hour to end 93.43 points higher (0.5%) at 17,784.05.
The $S&P 500 Index (.SPX.US)$ likewise added 4.67 ticks (0.1%) to...

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?

Movers and Shakers

8 hours ago

Columns Today's Pre-Market Movers and Top Ratings | FDX, NKE, QUBT and more

Morning Movers
Gapping Up
$Luminar Technologies (LAZR.US)$ jumped 7.2% after its fourth-quarter loss was less than anticipated and its $22.5 million in revenue exceeded the $17.8 million forecast. The company also reported an adjusted gross profit of $14 million, against Wall Street's expectation of a $12 million loss.
$Alnylam Pharmaceuticals (ALNY.US)$ increased 4.5% Premarket premarket after FDA expands approval for drug to trea...